Delivery Order SPE2DB24D1034-SPE2DB24FVZD8

Award Date 4/15/24
Potential Completion Date 5/6/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,549.75, is a delivery order for the pharmaceutical product Qulipta 60 mg tablet. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Qulipta 30 mg Tablets in quantities of 30. The $2,432.59 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major customer of Amerisourcebergen's federal contracting activities. The contract has an ultimate completion date of October 8, 2024 and is not designated as a set-aside. Amerisourcebergen, a large pharmaceutical distributor, holds...
This federal contract award, valued at $1,606.37, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of Qulipta 60 mg tablets, a pharmaceutical product. This is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $8,353.23 delivery order contract is for the supply of Qulipta 30 mg tablets, a prescription medication. The contract has a firm-fixed price and an ultimate completion date of August 21, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,531.13, is for the delivery of Qulipta 60 MG Tablet 30S, a pharmaceutical product. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. The company...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,872.51 firm fixed-price delivery order is for QULIPTA 30 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 5, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the procurement of QULIPTA 60 MG TABLET 30S. The $9,687.83 Firm Fixed Price Delivery Order contract has an ultimate completion date of January 17, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,232.42 firm fixed-price contract is for the supply of Qulipta 30 mg Tablets, a medication used to treat migraines. The contract has an ultimate completion date of March 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,153.06 firm fixed-price delivery order is for the QULIPTA 60 MG TABLET 30S medical product, with a completion date of July 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,589.83, is a Firm Fixed Price Delivery Order for QULIPTA 60 MG TABLET 30S. The contract has an ultimate completion date of March 20, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
  • SPE2DB24D1034
    Indefinite Delivery Contract
  • SPE2DB24D1034-SPE2DB24FVZD8
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,116.21, is for the delivery of the pharmaceutical product Qulipta 30 mg Tablet 30s. The contract is a delivery order with a firm fixed price and has an ultimate completion date of May 6, 2024.

Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, is fulfilling this contract as part of its broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.

The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis. Amerisourcebergen's expertise in pharmaceutical distribution and its extensive supply chain network have enabled the company to competitively secure this and other federal contract awards for supplying critical medical products to various government agencies, including the Department of Defense and the Department of Justice.

Generated 7/15/24, 6:58 PM